Active Pharmaceutical Ingredient Market Size Worth $306.1 Billion By 2027 | CAGR: 7.1% |
                     Active Pharmaceutical Ingredient   
  Market
Set to Exceed $306.1 Billion  by 2026 | CAGR 7.1%
Active Pharmaceutical Ingredient (API) Market Share, Size, 
Trends, Industry Analysis Report, By Product Type (mAb, 
Immunoglobulin, Cytokines, Insulin, Peptide Hormones, 
Blood Factors, Peptide Antibiotics, Vaccines, Small Molecule 
Antibiotics, Highly Potent Active Pharmaceutical Ingredient 
(HPAPI), and Others); By Form (Aqueous, Non-Aqueous 
Liquid, and Dry Powder); By Manufacturer Type (Captive, 
and Merchant); By Application; By Regions; Segment 
Forecast, 2020 - 2027
Active Pharmaceutical Ingredient Market Size Worth $306.1 Billion By 2027 | CAGR: 7.1%
The global active pharmaceutical ingredient (API) market size is expected to reach USD 
306.1 billion by 2027 according to a new study by Polaris Market Research. The report 
“Active pharmaceutical Ingredient (API) market Share, Size, Trends, Industry Analysis Report, 
By Product Type (Monoclonal Antibodies, Immunoglobulin, Cytokines, Insulin, Peptide 
Hormones, Blood Factors, Peptide Antibiotics, Vaccines, Small Molecule Antibiotics, Highly 
Potent Active Pharmaceutical Ingredient (HPAPI), and Others); By Form (Aqueous, Non-
Aqueous Liquid, and Dry Powder); By Manufacturer Type (Captive, and Merchant); By 
Application (Cardiology, Oncology, CNS & Neurology, Orthopedic, Endocrinology, 
Pulmonology, Gastroenterology, Nephrology, Ophthalmology, and Others), By Regions; 
Segment Forecast, 2020 –2027”gives a detailed insight into current market dynamics and 
provides analysis on future market growth.
 
Active Pharmaceutical Ingredient (API) is a substance involved in the finished 
pharmaceutical product (FPP), aimed to enhance the pharmacological activity or have direct 
impact in the cure, mitigation, diagnosis, treatment of disease or in modifying, correcting or 
restoring physiological functions in the human body. Drug products are composed of various 
components, API is the primary ingredient of a drug product, for instance, capsule or a 
tablet. APIs form used in Cotphyreigh t ©f Poorlamris Muarlkaett Rieosenar ch i&s C ontshulteing  LLmP 2o01s8.t A ll Rsigthats bRelseer vecd rystalline form, thermo- 2
dynamically. 
Active Pharmaceutical Ingredient Market
By Product Type By Form By Manufacturer Type By Application By Region
 Monoclonal Antibodies  Aqueous  Captive  Cardiology  North America (U.S., 
 Immunoglobulin  Non-Aqueous  Merchant  Oncology Canada)
 Cytokines  Dry Powder  CNS & Neurology  Europe (France, Germany, 
 Insulin  Orthopedic UK, Italy, Spain, 
 Peptide Hormones  Endocrinology Netherlands, Austria)
 Blood Factors  Pulmonology  Asia Pacific (Japan, China, 
 Peptide Antibiotics  Gastroenterology India, Malaysia, Indonesia. 
 Vaccines  Nephrology South Korea)
 Small Molecule  Ophthalmology  Latin America (Brazil, 
Antibiotics  Others Mexico, Argentina)
 Highly Potent Active  MEA (Saudi Arabia, UAE, 
Pharmaceutical Israel, South Africa)
Ingredient (HPAPI)
 Others Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 3
Active Pharmaceutical Ingredient (API) Market Estimate & Forecast to 2027
The prominent factors favoring the global market include the sudden outbreak of novel 
corona virus, which is rapidly escalating the demand for pharmaceuticals and thereby 
fueling the overall market growth. Additionally, rise in aging population, rising cases of 
cardiovascular diseases, cancer, AIDs, other infectious diseases, are further contributing to 
augmenting demand for APIs that are used in drugs. For instance, according to a report 
published in March 2020, by World Health Organization (WHO), the number of COVID-19 
patients increased to 200,000 and in almost after twelve-day period, the number would 
exceed by 100,000. Moreover, rising incidence of cardiovascular, oncology, diabetes and 
lifestyle diseases coupled with rising geriatric populace is furthermore surging the overall 
demand for the global market.
Access Research Report On Active Pharmaceutical Ingredient (API) Market Size
Market participants such as AbbVie Inc., Albemarle Corporation, AstraZeneca, Aurobindo 
Pharma, Boehringer Ingelheim, Bristol-Myers Squibb, Cipla Inc., Dr. Reddy’s Laboratories 
Ltd., ELI Lilly and Company, F. Hoffmann-La Roche, GlaxoSmithKline PLC, Lonza Group, 
Merck & Co., Inc., Mylan N.V., Novartis AG, Pfizer, Inc., Sanofi, Sun Pharmaceutical Industries 
Ltd, and Teva Pharmaceutical Industries Ltd. are some of the key players operating in the 
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 4
global market.
Active Pharmaceutical Ingredient (API) Market
Request for Sample
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 5
Active Pharmaceutical Ingredient (API) Market Study – Engagement Options
Buy Now – Click Here!
Buy now & have immediate access to premium insights
Purchase Report Sections – Click Here!
Regional analysis
Segmentation analysis
 Industry outlook
Competitive landscape
Speak To Analyst – Click Here!
Get your doubts clear
Schedule a call with our analyst before making any decision
Request For Sample Pages – Click Here!
Get free sample pages 
Understand report structure
Unmask data for validation
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 6
About Us
Polaris Market Research is a global market research and consulting company. The company 
specializes in providing exceptional market intelligence and in-depth business research services 
for our clientele spread across different enterprises. We at Polaris are obliged to e present across 
the industries of healthcare, technology, semi-conductors and chemicals among various other 
industries present around the world. 
We strive to provide our customers with updated information on innovative technologies, high 
growth markets, emerging business environments and latest business-centric applications, 
thereby helping them always to make informed decisions and leverage new opportunities. Adept 
with a highly competent, experienced and extremely qualified team of experts comprising SMEs, 
analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our 
customers.
 
Web: www.polarismarketresearch.com
Official Blog: https://cmfe-market-research-report.blogspot.com/
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 7
Thank You!
Contact Us :
Polaris Market Research
30 Wall Street
8th Floor, 
New York City, NY 10005,
United States
E mail Id: [email protected]
Phone: +1-646-568-9980